These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 32116)

  • 1. Plasma concentrations of methylergometrine after intravenous and intramuscular administration.
    Kanto J; Allonen H; Erkkola R; Kleimola T; Mantyla R
    Int J Gynaecol Obstet; 1978-1979; 16(2):173-4. PubMed ID: 32116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylergometrine (methylergonovine) concentrations in the human plasma and urine.
    Mäntylä R; Kleimola T; Kanto J
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):254-7. PubMed ID: 669870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and tissue concentrations of methylergometrine (methylergonovine) in the rabbit.
    Mäntylä R; Kanto J; Kleimola T; Seppälä M
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):245-9. PubMed ID: 7368943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylergometrine: comparison of plasma concentrations and clinical response of two brands.
    Allonen H; Juvakoski R; Kanto J; Laitinen S; Mäntylä R; Kleimola T
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):340-2. PubMed ID: 352975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excretion of methylergometrine (methylergonovine) into the human breast milk.
    Erkkola R; Kanto J; Allonen H; Kleimola T; Mäntylä R
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):579-80. PubMed ID: 730424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of methylergometrine (methylergonovine) in the rabbit and man.
    Mäntylä R; Kleimola T; Kanto J
    Acta Pharmacol Toxicol (Copenh); 1977 May; 40(5):561-9. PubMed ID: 577369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of methylergometrine (methylergonovine).
    Mäntylä R; Kanto J
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):386-91. PubMed ID: 7298246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of methylergometrine in the breast milk of dogs.
    Mäntylä R
    Eur J Drug Metab Pharmacokinet; 1980; 5(1):21-4. PubMed ID: 7389747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of methysergide and its metabolite methylergometrine in man.
    Bredberg U; Eyjolfsdottir GS; Paalzow L; Tfelt-Hansen P; Tfelt-Hansen V
    Eur J Clin Pharmacol; 1986; 30(1):75-7. PubMed ID: 3709634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of methylergonovine maleate in augmenting extraamniotic saline for midtrimester abortion.
    Narvekar MR; Pachauri S; Mhatre V; Ganguli AC
    Int J Gynaecol Obstet; 1978; 15(6):545-7. PubMed ID: 29806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial of intramuscular OCM 505 and intravenous methergin in the third stage of labour.
    Carpén E; Koistinen O; Virkkunen A; Laakso L
    Ann Chir Gynaecol Fenn; 1968; 57(4):473-5. PubMed ID: 4893747
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the bioavailability and pharmacokinetics of oral methylergometrine in men and women.
    de Groot AN; Vree TB; Hekster YA; van den Biggelaar-Martea M; van Dongen PW; van Roosmalen J
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):328-32. PubMed ID: 7582383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic study with synthetic salmon calcitonin (Sandoz).
    Beveridge T; Niederer W; Nüesch E; Petrin A
    Z Gastroenterol Verh; 1976; (10):12-5. PubMed ID: 64046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor.
    Fujimoto M; Takeuchi K; Sugimoto M; Maruo T
    Acta Obstet Gynecol Scand; 2006; 85(11):1310-4. PubMed ID: 17091409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental transfer and pharmacokinetics of atropine after a single maternal intravenous and intramuscular administration.
    Kanto J; Virtanen R; Iisalo E; Mäenpää K; Liukko P
    Acta Anaesthesiol Scand; 1981 Apr; 25(2):85-8. PubMed ID: 7324829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2.
    Ylikorkala O; Mäkilä UM; Viinikka L
    Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of methylergometrine shows a late and unpredictable effect on the non-pregnant human menstruating uterus.
    de Groot AN; van Dongen PW; Vree TB; Eskes TK
    Eur J Obstet Gynecol Reprod Biol; 1995 Jun; 60(2):101-7. PubMed ID: 7641959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of methylergometrine on the course of the third stage of labor].
    Zarzycki H
    Ginekol Pol; 1969 Jan; 40(1):29-34. PubMed ID: 5780810
    [No Abstract]   [Full Text] [Related]  

  • 19. Disposition of HI-6 oxime in rats after intravenous and intramuscular administration.
    Simons KJ; Briggs CJ
    J Pharm Pharmacol; 1985 May; 37(5):367-9. PubMed ID: 2862253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). I. Absorption, distribution, metabolism and excretion in rats].
    Suzuki T; Serizawa K; Somiya Y; Shirai M; Endo S; Morishita M
    Jpn J Antibiot; 1987 Jan; 40(1):188-201. PubMed ID: 3586328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.